Connecting Research and Experts with Journalists

• share
• favorite_border

Researchers at The University of Texas M. D. Anderson Cancer Center have shined a bold new light on the future treatment of childhood leukemia. Results of a study published in the Jan. 30 issue of the New England Journal of Medicine not only refute a 30-year-old dogma universally held by the medical community, but also open new doors to a better understanding of acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. Using two sensitive assays, M. D. Anderson researchers found that up to thousands of leukemia cells may remain in a patient long after successful treatment.

• share
• favorite_border

EMBARGOED FOR RELEASE UNTIL 5 p.m., EST, THURSDAY, MARCH 27 HOUSTON -- Researchers at The University of Texas M. D. Anderson Cancer Center, in collaboration with Myriad Genetics, Inc. of Salt Lake City, have discovered a gene involved in the progression of a fatal form of brain cancer and a number of other cancers.

• share
• favorite_border

Postmenopausal women with advanced breast cancer treated with a new aromatase inhibitor live longer than patients treated with a commonly-used progestin, according to a report given today at the American Society of Clinical Oncology (ASCO).

• share
• favorite_border

Researchers at The University of Texas M. D. Anderson Cancer Center have found another anti-tumor drug that may prove useful in fighting lung cancer associated with smoking. The clinical trial at the Houston cancer center indicates the drug, topotecan, shows promise as a new treatment option for patients suffering from advanced non-small cell lung cancer.

• share
• favorite_border

An international study has found a new agent that may prove useful for treating patients with an aggressive brain tumor known as anaplastic astrocytoma.

• share
• favorite_border

Cancer patients wanting cutting-edge therapy or whose disease no longer responds to traditional treatment may find new hope on the "information super highway." The University of Texas M. D. Anderson Cancer Center has posted its clinical trials available for cancer patients on a World Wide Web site.

• share
• favorite_border

Findings of the Phase I medical study may have a huge impact on future treatments for the disease, especially for men with localized advanced prostate cancer, say Researchers at the University of Texas M. D. Anderson Cancer Centerr.

• share
• favorite_border

Smokers successfully treated for head and neck squamous cell cancer have greater chances of getting another cancer or having the cancer recur if they do not quit smoking, according to study at the University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

1- effectiveness of first oral chemotherapy for colon cancer; 2- new agent's promise against most serious brain tumors; 3- Taxotere increases survival rate for patients with non-small cell lung cancer.

• share
• favorite_border

The University of Texas M. D. Anderson Cancer Center is recruiting women for one of the largest breast cancer prevention studies conducted to date.

• share
• favorite_border

The program, Prostate Cancer: A Journey of Hope, airs in some cities Friday, June 11, and stresses the importance of early detection for the disease, as well as the recommendation that men age 50 and older obtain an annual Prostate Specific Antigen (PSA) blood test and a digital rectal exam.

• share
• favorite_border

Three physicians at the University of Texas M. D. Anderson Cancer Center are major architects of new prostate cancer detection and treatment guidelines released today by the National Comprehensive Cancer Network and the American Cancer Society.

• share
• favorite_border

Hundreds of cancer survivors, their families, friends and health care professionals from Texas and the nation will gather Sept. 24-25 for a conference that has become an annual celebration of survivorship.

• share
• favorite_border

A new outpatient Center for Sympton Control andPalliative Care has opened at The University of Texas M. D. Anderson Cancer Center under the direction of Dr. Eduardo Bruera, newly appointed chairman of the Department of Symptom Control and Palliative Care.

• share
• favorite_border

Researchers at the University of Texas M. D. Anderson Cancer Center have discovered how the body defends itself against skin cancer.

• share
• favorite_border

Oncologists who learn how to communicate bad news and better handle patients' emotional reactions may improve their patients' quality of life, according to physicians at The University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

Studies of a drug for adults with a fatal form of brain cancer reportedly prolongs life with few side effects, say researchers at The University of Texas M. D. Anderson Cancer Center.

• share
• favorite_border

For a growing number of persons with cancer, there is life after their disease.

• share
• favorite_border

Dr. Margaret Kripke of The University of Texas M. D. Anderson Cancer Center has been honored by two professional societies for her research in skin cancer.

• share
• favorite_border

Research in ovarian cancer will be among the topics discussed at The Healthy Woman's Symposium hosted by M. D. Anderson Thursday, Oct. 21.